GLRX3 and cancer: Among the LRIG1 interactors, ZBTB16 and receptor-like protein tyrosine phosphatase (PTPRK) showed moderate but consistent positive correlations with LRIG1 expression in both cancer tissues and normal tissues, whereas GLRX3 showed a moderate but consistent negative correlation with LRIG1 expression in both cancer and normal tissues.